Browsing by Subject "integrative omics analysis"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Free Fatty Acids Rewire Cancer Metabolism in Obesity-Associated Breast Cancer via Estrogen Receptor and mTOR Signaling
    (AACR, 2019-05) Madak-Erdogan, Zeynep; Band, Shoham; Zhao, Yiru C.; Smith, Brandi P.; Kulkoyluoglu-Cotul, Eylem; Zuo, Qianying; Casiano, Ashlie Santaliz; Wrobel, Kinga; Rossi, Gianluigi; Smith, Rebecca L.; Kim, Sung Hoon; Katzenellenbogen, John A.; Johnson, Mariah L.; Patel, Meera; Marino, Natascia; Storniolo, Anna Maria V.; Flaws, Jodi A.; Medicine, School of Medicine
    Obesity is a risk factor for postmenopausal estrogen receptor alpha (ERα)-positive (ER+) breast cancer. Molecular mechanisms underlying factors from plasma that contribute to this risk and how these mechanisms affect ERα signaling have yet to be elucidated. To identify such mechanisms, we performed whole metabolite and protein profiling in plasma samples from women at high risk for breast cancer, which led us to focus on factors that were differentially present in plasma of obese versus nonobese postmenopausal women. These studies, combined with in vitro assays, identified free fatty acids (FFA) as circulating plasma factors that correlated with increased proliferation and aggressiveness in ER+ breast cancer cells. FFAs activated both the ERα and mTOR pathways and rewired metabolism in breast cancer cells. Pathway preferential estrogen-1 (PaPE-1), which targets ERα and mTOR signaling, was able to block changes induced by FFA and was more effective in the presence of FFA. Collectively, these data suggest a role for obesity-associated gene and metabolic rewiring in providing new targetable vulnerabilities for ER+ breast cancer in postmenopausal women. Furthermore, they provide a basis for preclinical and clinical trials where the impact of agents that target ERα and mTOR signaling cross-talk would be tested to prevent ER+ breast cancers in obese postmenopausal women.